12 Safe Stocks to Buy for the Long Term in 2025

Page 5 of 12

8. Pfizer Inc. (NYSE:PFE)

Number of Hedge Fund Holders: 80 

Pfizer Inc. (NYSE:PFE) discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. This company stands as a top investment choice for a variety of reasons. To begin with, the report for the third quarter shows a compelling investment opportunity. The company reported revenues of $17.7 billion, representing 32% year-over-year operational growth. Also, revenues were $13.6 billion, excluding the company’s COVID-19 products, which reflects an operational increase of 14% compared with the prior-year quarter. This underscores the company’s strong financial growth driven by a combination of contributions from Pfizer’s Oncology products, key in-line products, recent commercial launches, and heightened demand for its COVID-19 oral treatment. Secondly, the company has collaborated with The City University of New York (CUNY) Institute for Implementation Science in Population Health (ISPH), which has initiated a critical two-year prospective epidemiologic study to track acute respiratory infections across the United States.

Page 5 of 12